PubRank

Ming-Chin Yu

Author PubWeight™ 34.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. J Hepatol 2012 2.03
2 Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage. J Hepatol 2009 1.82
3 Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma. J Surg Oncol 2012 1.63
4 Adverse outcomes in patients with postoperative ascites after liver resection for hepatocellular carcinoma. World J Surg 2012 1.56
5 Significance of tumor necrosis for outcome of patients with hepatocellular carcinoma receiving locoregional therapy prior to liver transplantation. Ann Surg Oncol 2011 1.50
6 Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma. Mol Carcinog 2010 1.27
7 Adenosquamous/squamous cell carcinoma of the gallbladder. J Surg Oncol 2007 1.16
8 Single-centre results of treatment of retroperitoneal and mesenteric cystic lymphangiomas. Dig Surg 2007 1.03
9 Surgical management of giant hepatic hemangiomas: complications and review of the literature. Chang Gung Med J 2012 1.02
10 Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis. World J Surg 2003 1.00
11 The impact of CD4+ CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma. Surgery 2011 0.95
12 Outcomes of resection for colorectal cancer hepatic metastases stratified by evolving eras of treatment. World J Surg Oncol 2011 0.94
13 Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma. Hepatology 2011 0.94
14 Efficacy of surgical resection in management of isolated extrahepatic metastases of hepatocellular carcinoma. World J Gastroenterol 2009 0.93
15 Characterization of hepatocellular carcinoma recurrence after liver transplantation: perioperative prognostic factors, patterns, and outcome. Asian J Surg 2011 0.92
16 Surgical resection of centrally located large hepatocellular carcinoma. Chang Gung Med J 2012 0.91
17 Liver resection for complicated hepatocellular carcinoma: challenges but opportunity for long-term survivals. J Surg Oncol 2012 0.87
18 Gallbladder carcinoma with biliary invasion: clinical analysis of the differences from nonbiliary invasion. World J Surg 2005 0.87
19 Duodenal duplication cyst: a rare cause of geriatric gastrointestinal bleeding. J Chin Med Assoc 2011 0.86
20 Secreted ERBB3 isoforms are serum markers for early hepatoma in patients with chronic hepatitis and cirrhosis. J Proteome Res 2011 0.86
21 Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus. Ann Surg 2014 0.86
22 Using indocyanine green test to avoid post-hepatectomy liver dysfunction. Chang Gung Med J 2007 0.84
23 Hepatic resection for hepatocellular carcinoma with lymph node metastasis: clinicopathological analysis and survival outcome. Asian J Surg 2011 0.83
24 A case of huge primary liposarcoma in the liver. World J Gastroenterol 2006 0.83
25 Prognostic impact of Fas ligand on hepatocellular carcinoma after hepatectomy. World J Surg 2004 0.82
26 Clinical analysis and strategy for liver transplantation in patients with pre-existing portal vein thrombosis. Chang Gung Med J 2011 0.82
27 The expression of cytokeratin 19 in lymph nodes was a poor prognostic factor for hepatocellular carcinoma after hepatic resection. World J Surg Oncol 2013 0.81
28 Outcome of perforated gastric cancer: twenty years experience of one institute. Hepatogastroenterology 2011 0.80
29 Aggressive multimodality treatment for intra-hepatic recurrence of hepatocellular carcinoma following hepatic resection. Chang Gung Med J 2005 0.80
30 Imatinib mesylate improves liver regeneration and attenuates liver fibrogenesis in CCL4-treated mice. J Gastrointest Surg 2011 0.79
31 Functional genomics identified a novel protein tyrosine phosphatase receptor type F-mediated growth inhibition in hepatocarcinogenesis. Hepatology 2014 0.78
32 Analysis of the recurrence risk factors for the patients with hepatocellular carcinoma meeting University of California San Francisco criteria after curative hepatectomy. World J Surg Oncol 2011 0.76
33 Risk factors for early mortality after hepatectomy for hepatocellular carcinoma. Medicine (Baltimore) 2016 0.75
34 Patient outcomes following surgical management of multinodular goiter: Does multinodularity increase the risk of thyroid malignancy? Medicine (Baltimore) 2016 0.75
35 The Preference for Anterior Approach Major Hepatectomy: Experience Over 3 Decades and a Propensity Score-Matching Analysis in Right Hepatectomy for Hepatocellular Carcinoma. Medicine (Baltimore) 2015 0.75